Celularity Non Current Assets Total vs Cash Analysis
CELU Stock | USD 3.43 0.21 5.77% |
Celularity financial indicator trend analysis is way more than just evaluating Celularity prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Celularity is a good investment. Please check the relationship between Celularity Non Current Assets Total and its Cash accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Celularity. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis. For more information on how to buy Celularity Stock please use our How to Invest in Celularity guide.
Non Current Assets Total vs Cash
Non Current Assets Total vs Cash Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Celularity Non Current Assets Total account and Cash. At this time, the significance of the direction appears to have strong relationship.
The correlation between Celularity's Non Current Assets Total and Cash is 0.76. Overlapping area represents the amount of variation of Non Current Assets Total that can explain the historical movement of Cash in the same time period over historical financial statements of Celularity, assuming nothing else is changed. The correlation between historical values of Celularity's Non Current Assets Total and Cash is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Non Current Assets Total of Celularity are associated (or correlated) with its Cash. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Cash has no effect on the direction of Non Current Assets Total i.e., Celularity's Non Current Assets Total and Cash go up and down completely randomly.
Correlation Coefficient | 0.76 |
Relationship Direction | Positive |
Relationship Strength | Significant |
Non Current Assets Total
The total value of a company's long-term assets, which are not expected to be converted into cash or used up within one year or the operating cycle, including property, plant, and equipment, and intangible assets.Cash
Cash refers to the most liquid asset of Celularity, which is listed under current asset account on Celularity balance sheet and usually includes currency, coins, checking accounts, and not deposited checks received from Celularity customers. The amounts must be unrestricted with restricted cash listed in a different Celularity account. The total amount of money in the form of currency that a company has in its possession. This includes all bills, coins, and funds in bank accounts.Most indicators from Celularity's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Celularity current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Celularity. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis. For more information on how to buy Celularity Stock please use our How to Invest in Celularity guide.At this time, Celularity's Tax Provision is comparatively stable compared to the past year. Enterprise Value is likely to gain to about 313.1 M in 2024, whereas Selling General Administrative is likely to drop slightly above 49.4 M in 2024.
2021 | 2022 | 2023 | 2024 (projected) | Total Operating Expenses | 159.7M | 146.6M | 136.3M | 117.0M | Cost Of Revenue | 9.7M | 19.7M | 11.7M | 11.5M |
Celularity fundamental ratios Correlations
Click cells to compare fundamentals
Celularity Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Celularity fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 291.6M | 431.0M | 414.1M | 401.1M | 461.2M | 338.4M | |
Short Long Term Debt Total | 28.1M | 30.6M | 31.1M | 65.6M | 75.4M | 79.2M | |
Other Current Liab | (3.5M) | 13.5M | 11.7M | 16.4M | 18.9M | 19.8M | |
Total Current Liabilities | 229.1K | 26.7M | 26.2M | 62.1M | 71.4M | 75.0M | |
Total Stockholder Equity | 263.4M | (531.4M) | 99.4M | 198.9M | 228.7M | 240.2M | |
Other Liab | 334.9M | 358.0M | 260.4M | 112.1M | 100.9M | 95.8M | |
Net Tangible Assets | (726.0M) | 214.1M | (147.1M) | (41.8M) | (48.1M) | (50.5M) | |
Net Debt | 27.1M | (23.7M) | (6.1M) | 51.6M | 59.4M | 62.3M | |
Retained Earnings | 3.9M | (563.6M) | (663.7M) | (645.5M) | (580.9M) | (610.0M) | |
Accounts Payable | 3.7M | 5.4M | 9.3M | 5.8M | 6.7M | 6.5M | |
Cash | 917.0K | 54.3M | 37.2M | 14.0M | 16.1M | 23.4M | |
Non Current Assets Total | 290.6M | 358.8M | 376.9M | 367.6M | 422.7M | 306.7M | |
Non Currrent Assets Other | (464.9M) | 20.1M | 39.8M | 23.3M | 26.8M | 28.2M | |
Cash And Short Term Investments | 917.0K | 54.3M | 37.2M | 14.0M | 16.1M | 23.4M | |
Net Receivables | 3.1M | 6.6M | 5.2M | 7.0M | 8.0M | 5.7M | |
Liabilities And Stockholders Equity | 291.6M | 431.0M | 414.1M | 401.1M | 461.2M | 338.4M | |
Inventory | 3.2M | 3.9M | 9.5M | 5.3M | 6.1M | 5.6M | |
Other Current Assets | 92.2K | 873K | 2K | 9.8M | 11.2M | 11.8M | |
Other Stockholder Equity | 259.5M | 32.2M | 763.1M | 443.3M | 509.8M | 329.6M | |
Total Liab | 28.2M | 962.4M | 314.7M | 202.2M | 232.5M | 331.7M | |
Total Current Assets | 1.0M | 72.2M | 37.2M | 33.5M | 38.5M | 31.7M | |
Common Stock | 258.4M | 1K | 12K | 15K | 13.5K | 12.8K |
Pair Trading with Celularity
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Celularity position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Celularity will appreciate offsetting losses from the drop in the long position's value.Moving together with Celularity Stock
0.61 | JNJ | Johnson Johnson Aggressive Push | PairCorr |
Moving against Celularity Stock
0.5 | MRK | Merck Company Financial Report 6th of August 2024 | PairCorr |
The ability to find closely correlated positions to Celularity could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Celularity when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Celularity - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Celularity to buy it.
The correlation of Celularity is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Celularity moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Celularity moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Celularity can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Celularity. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis. For more information on how to buy Celularity Stock please use our How to Invest in Celularity guide.You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
Complementary Tools for Celularity Stock analysis
When running Celularity's price analysis, check to measure Celularity's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Celularity is operating at the current time. Most of Celularity's value examination focuses on studying past and present price action to predict the probability of Celularity's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Celularity's price. Additionally, you may evaluate how the addition of Celularity to your portfolios can decrease your overall portfolio volatility.
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Global Correlations Find global opportunities by holding instruments from different markets | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Stocks Directory Find actively traded stocks across global markets |
Is Celularity's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Celularity. If investors know Celularity will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Celularity listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.93) | Earnings Share (10.30) | Revenue Per Share 0.887 | Quarterly Revenue Growth (0.08) | Return On Assets (0.20) |
The market value of Celularity is measured differently than its book value, which is the value of Celularity that is recorded on the company's balance sheet. Investors also form their own opinion of Celularity's value that differs from its market value or its book value, called intrinsic value, which is Celularity's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Celularity's market value can be influenced by many factors that don't directly affect Celularity's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Celularity's value and its price as these two are different measures arrived at by different means. Investors typically determine if Celularity is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Celularity's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.